Effect of cytostatic drugs on microbial behaviour in membrane bioreactor system

Bioresource Technology

Volumn 101, Issue 2, 2010, Pages 527-536

  Delgado, Luis F ^a   Schetrite, Sylvie ^a   Gonzalez, Carlos ^a   Albasi, Claire ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Activated sludge; Cyclophosphamide; Membrane bioreactor; Micropollutants; Respirometry

Indexed keywords

ACTIVATED SLUDGE; CYCLOPHOSPHAMIDE; MEMBRANE BIOREACTOR; MICROPOLLUTANTS; RESPIROMETRY;

ACTIVATED SLUDGE PROCESS; BIOACTIVITY; BIOCONVERSION; BIOMASS; MEMBRANES; METABOLISM; MICROORGANISMS;

BIOREACTORS;

CARBON; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DRUG METABOLITE;

ACTIVATED SLUDGE; BIOREACTOR; CATABOLISM; DRUG; INHIBITION; LABORATORY METHOD; MEMBRANE; MICROBIAL ACTIVITY; MICROORGANISM; POLLUTANT REMOVAL; RESPIRATION;

ARTICLE; ARTIFICIAL MEMBRANE; BIOMASS; BIOREACTOR; BIOSYNTHESIS; BREATHING RATE; CATABOLISM; CHEMICAL STRESS; CONTROLLED STUDY; ENERGY; HETEROTROPH; MICROBIAL ACTIVITY; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; SLUDGE; WASTE WATER MANAGEMENT;

ANTINEOPLASTIC AGENTS; BIOREACTORS; MEMBRANES, ARTIFICIAL; MICROBIOLOGY; OXYGEN; PILOT PROJECTS; SEWAGE;

EID: 70349433519     PISSN: 09608524     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biortech.2009.08.051     Document Type: Article

References (32)

1. Buerge I.J., Buser H.R., Poiger T., and Müller M.D. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environmental Science and Technology 40 (2006) 7242-7250
2. Byrns G. The fate of xenobiotic organic compounds in wastewater treatment plants. Water Research 35 (2001) 2523
3. Delgado, L.F., Dorandeu, C., Marion, B., Gonzales, C., Faucet-Marquis, V., Schetrite, S., Albasi, C., in press. Removal of a cytostatic drug by a membrane bioreactor. Desalination and water treatment.
4. Dionisi D., Bertin L., Bornoroni L., Capodicasa S., Petrangeli Papini M., and Fava F. Removal of organic xenobiotics in activated sludges under aerobic conditions and anaerobic digestion of the adsorbed species. Journal of Chemical Technology and Biotechnology 81 (2006) 1496
5. Dionisi D., Levantesi C., Majone M., Bornoroni L., and De Sanctis M. Effect of micropollutants (organic xenobiotics and heavy metals) on the activated sludge process. Industrial and Engineering Chemistry Research 46 (2007) 6762-6769
6. Halling-Sorensen B., Nors Nielsen S., Lansky P.F., Ingerslev F., Holten Lützhoft C., and Jorgensen E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36 (1998) 357-393
7. Henriques I.D.S., and Love N.G. The role of extracellular polymeric substances in the toxicity response of activated sludge bacteria to chemical toxins. Water Research 41 18 (2007) 4177-4185
8. Henze M., Harremoes P., Jansen J.L.C., and Arvin E. Wastewater Treatment: Biological and Chemical Processes. third ed. (2001), Springer Verlag, Berlin Heidelberg. 3-540-42228-5
9. Huitema Alwin D.R., Cindy R., Tibben Matthijs M., Rodenhuis Sjoerd, and Beijne Jos H. Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasma. Journal of Chromatography B 757 2001 (2001) 349-357
10. Johnson A.C., Jürgens M.D., Williams R.J., Kümmerer K., Kortenkamp A., and Sumpter J.P. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. Journal of Hydrology 348 (2008) 167-175
11. Joqueviel C., Martino R., Gilard V., Malet-Martino M., Canal P., and Niemeyer U. Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Drug metabolism and Disposition 26 5 (1998) 418-428
12. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 45 (2001) 957-969
13. Lenz K., Hann S., Koellensperger G., Stefánka Z., Stingeder G., Weissenbacher N., Mahnik S.N., and Fuerhacker M. Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge. Science of the Total Environment 345 (2005) 141-152
14. Lenz K., Koellensperger G., Hann S., Weissenbacher N., Mahnik S.N., and Fuerhacker M. Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 69 (2007) 1765-1774
15. Liu Y., and Fang Herbert H.P. Influences of extracellular polymeric substances (EPS) on flocculation, settling and dewatering of activated sludge. Critical Reviews in Environmental Science and Technology 33 3 (2003) 237-273
16. Love N.G., and Bott C.B. Evaluating the role of microbial stress response mechanisms in causing biological treatment system upset. Water Science and Technology 46 1-2 (2002) 11-18
17. Low E.W., and Chase H.A. Reducing production of excess biomass during wastewater treatment. Water Research 33 5 (1999) 1119-1132
18. Low E.W., and Chase H.A. The effect of maintenance energy requirements on biomass production during wastewater treatment. Water Research 33 3 (1999) 847-853
19. Mahnik S.N., Lenz K., Weissenbacher N., Mader R.M., and Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio- reactor system. Chemosphere 66 (2007) 30-37
20. Moore M.J. Clinical pharmacokinetics of cyclophosphamide. Clinical Pharmacokinetics 20 (1991) 194-208
21. Paxeus N. Organic pollutants in the effluents of large wastewater treatment plants in Sweden. Water Research 30 5 (1996) 1115-1122
22. Pirt S.J. Principles of Microbe and Cell Cultivation (1975), Blackwell Scientific Publications, London, UK
23. Ray S., and Peters C.A. Changes in microbiological metabolism under chemical stress. Chemosphere 71 (2008) 474-483
24. Rodde-Pellegrin M.L., Wisniewski C., Grasmick A., Tazi-pain A., and Buisson H. Respirometric needs of heterotrophic populations developed in an immersed membrane bioreactor working in sequenced aeration. Biochemical Engineering Journal 11 (2002) 2-12
25. Sarmah A.K., Meyer M.T., and Boxall A.B.A. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65 (2006) 725-759
26. Sladek N.E. Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. In: Powis G. (Ed). Anticancer Drugs: Reactive Metabolism and Drug Interactions (1994), Pergamon Press, Oxford, UK 79-156
27. Spanjers H., Vanrolleghem P.A., Olsson G., and Dold PL. Respirometry in Control of the Activated Sludge Process: Principles. IAWQ Scientific and Technical Report No. 7 (1998), IAWQ Publishing, London, UK
28. Steger-Hartmann T., Kümmerer K., and Hartmann A. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicology and Environmental Safety 36 (1997) 174-179
29. Urase T., and Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Research 39 (2005) 1289
30. Vanrolleghem P.A., Spanjers H., Petersen B., Ginestet P., and Takacs I. Estimating (combinations of) activated sludge model No. 1 parameters and components by respirometry. Water Science Technology 39 1 (1999) 195-214
31. Wingender J., Neu T.R., and Flemming H.C. What are bacterial extracellular polymer substances?. In: Wingender J., Neu T.R., and Flemming H.C. (Eds). Microbial Extracellular Polymeric Substances (1999), Springer, Heidelberg 1-19
32. Witzig R., Manz W., Rosenberger S., Krüger U., Kraume M., and Szewzyk U. Microbiological aspects of a bioreactor with submerged membranes for aerobic treatment of municipal wastewater. Water Research 36 2 (2002) 394-402